Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

116.98
Delayed Data
As of Apr 17
 -4.39 / -3.62%
Today’s Change
47.03
Today|||52-Week Range
123.72
+20.60%
Year-to-Date

Today’s Trading

Previous close121.37
Today’s open120.45
Day’s range115.97 - 121.03
Volume835,664
Average volume (3 months)762,319
Market cap$9.8B
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+38.62%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book9.65

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.79-1.17%
ISISIsis Pharmaceuticals...-0.98-1.48%
ICLRICON PLC+0.14+0.20%
DYAXDyax Corp-0.46-1.62%
Data as of 4:04pm ET, 04/17/2015

Financials

Next reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers